Pharmaceutical sector in 10 years to completely change

Financial consulting and auditing firm Deloitte, pharmaceutical, medical device and biotechnology fields, including health sector discuss the "Future of the Health Sector: Strategies for Success 2015'te" The report was released. Performed by The Economist Intelligence Unit of the organization based on the research according to the report, the sector is expecting major changes in the next ten years. Even in the future of the pharmaceutical companies do not have a portfolio of innovative medicines, yet be connected.



The report, carried out various researches in the health sector emerged as a result. March-April 2006 survey performed in 193 high-level managers and administrators participating in the business until 2015, and the success of what will change in the way in which strategy to adopt will have to answer questions. The report is being prepared, a round table meeting in June 2006, as well as global pharmaceutical, medical device and biotechnology companies with CEO DVDs and board members about the future of the industry and the company was held.

According to the report, the country of changes in demographic structure and population aging and changes in the appearance of diseases, new technologies to market entry, such as significant increase in health costs are factors operating in the sector of firms in business strategy needs to make serious changes.

The report also forms a major part of the health sector, pharmaceutical companies will need to develop a portfolio of innovative products is foreseen. Health sector companies operating in the next ten years to ensure success in the enterprise is required to set priorities. However, the company has not determined yet the corporate priorities. These companies will face in the future, standing in the competitive environment remains challenging new business models will need to be able to.

Health sector very difficult, but at the same time the prize is high, that indicates a waiting period Deloitte Turkey Tax Services Specialist Partners and Healthcare Industry Leader Zeki Kurt client, in the future of the sector will change down was expressed. Kurt client, in the description on the subject, said: "The most important sectors of the future will take place between companies in the health sector in developing countries will be more directed. Turkey's need to bring incentives to improve investment environment, developing infrastructure and people to benefit from these waves is important. And strategies for the coming period can read correctly, the right of companies and countries can draw from this growing economy will make the most of its blessings. "

Criteria for success will remain the same

According to the report, between 2006 and 2015 many things will change, but the company will not change the criteria for success: a profitable growth, the strength of high reputation and product portfolio.

Deloitte'un study, the future of the health sector, especially in terms of pharmaceutical companies, yet does not have a portfolio of products and services will depend on being saved. Companies reducing their costs, many more will have to offer innovative products to market. R & D approach by reviewing the need to make more effective sales and marketing company, the traditional approach will also be forced to change. Especially with the new drugs is extremely aggressive marketing strategy, has become increasingly politically unacceptable. These strategies better to focus on consumers will need to be rearranged.

Traditional strategies for commercial product to be effective. Companies in this issue and users will consider regulatory and industry will need to develop new approaches.

Araştırmada, companies in the health sector will have 2015'te critical thinking as the activity occurs is still not experts. Many of the companies to develop significant expertise in core areas is required. Recruit the best human resources and retention is important to you.

THE IMPORTANCE OF ART in developing markets is

Markets are developing in the future of the sector will play a big role. Companies are developing markets, R & D, including a wide range of activities will require a significant amount of investment. Until the year 2015 total revenue of firms in this sector to developing countries more than 25 percent is expected to get them.

Research katılan an important part of CEO among developing countries, China has placed on the top. Countries, high population, low costs and rapid economic growth in the healthcare sector looks attractive. The second sequence, robust economy, stable markets and low costs in this sector can produce products and services of Central European countries, sitting, and a large domestic market but also suitable for R & D has a business infrastructure that India was the third. Between Russia and the large number of qualified technicians and also with researchers in Eastern Europe between the eye of investors are in fourth position.

Significant growth in organic revenue in the sector of road will have to provide, mergers and acquisitions will continue. Important as a way to generate revenue of partnerships / alliances arise. Companies need to take advantage of partnership common in academic circles, and the receivers (the public and private) sectors to establish partnerships and links that could.